{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T01:08:37Z","timestamp":1790471317401,"version":"4.1.0"},"reference-count":106,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2018,1,16]],"date-time":"2018-01-16T00:00:00Z","timestamp":1516060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Both acute and chronic liver toxicity represents a major global health burden and an important cause of morbidity and lethality worldwide. Despite epochal progress in the treatment of hepatitis C virus infections, pharmacological treatment strategies for most liver diseases are still limited and new targets for prevention or treatment of liver disease are urgently needed. MicroRNAs (miRNAs) represent a new class of highly conserved small non-coding RNAs that are involved in the regulation of gene expression by targeting whole networks of so called \u201ctargets\u201d. Previous studies have shown that the expression of miRNAs is specifically altered in almost all acute and chronic liver diseases. In this context, it was shown that miRNA can exert causal roles, being pro- or anti-inflammatory, as well as pro- or antifibrotic mediators or being oncogenes as well as tumor suppressor genes. Recent data suggested a potential therapeutic use of miRNAs by targeting different steps in the hepatic pathophysiology. Here, we review the function of miRNAs in the context of acute and chronic liver diseases. Furthermore, we highlight the potential role of circulating microRNAs in diagnosis of liver diseases and discuss the major challenges and drawbacks that currently prevent the use of miRNAs in clinical routine.<\/jats:p>","DOI":"10.3390\/ijms19010261","type":"journal-article","created":{"date-parts":[[2018,1,17]],"date-time":"2018-01-17T04:23:44Z","timestamp":1516163024000},"page":"261","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":128,"title":["The Role of miRNAs in the Pathophysiology of Liver Diseases and Toxicity"],"prefix":"10.3390","volume":"19","author":[{"given":"Florian","family":"Schueller","sequence":"first","affiliation":[{"name":"Department of Medicine III, University Hospital RWTH Aachen, Pauwelsstrasse 30, 52074 Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanchari","family":"Roy","sequence":"additional","affiliation":[{"name":"Department of Medicine III, University Hospital RWTH Aachen, Pauwelsstrasse 30, 52074 Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihael","family":"Vucur","sequence":"additional","affiliation":[{"name":"Department of Medicine III, University Hospital RWTH Aachen, Pauwelsstrasse 30, 52074 Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Trautwein","sequence":"additional","affiliation":[{"name":"Department of Medicine III, University Hospital RWTH Aachen, Pauwelsstrasse 30, 52074 Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Luedde","sequence":"additional","affiliation":[{"name":"Department of Medicine III, University Hospital RWTH Aachen, Pauwelsstrasse 30, 52074 Aachen, Germany"},{"name":"Division of Gastroenterology, Hepatology and Hepatobiliary Oncology, University Hospital RWTH Aachen, Pauwelsstrasse 30, 52074 Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Roderburg","sequence":"additional","affiliation":[{"name":"Department of Medicine III, University Hospital RWTH Aachen, Pauwelsstrasse 30, 52074 Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,1,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrg2843","article-title":"The widespread regulation of microRNA biogenesis, function and decay","volume":"11","author":"Krol","year":"2010","journal-title":"Nat. Rev. Genet."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/nsmb1167","article-title":"RNA polymerase iii transcribes human microRNAs","volume":"13","author":"Borchert","year":"2006","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2174\/138920210793175895","article-title":"microRNA: Biogenesis, function and role in cancer","volume":"11","author":"Macfarlane","year":"2010","journal-title":"Curr. Genom."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","article-title":"The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14","volume":"75","author":"Lee","year":"1993","journal-title":"Cell"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.cell.2007.04.040","article-title":"A mammalian microRNA expression atlas based on small RNA library sequencing","volume":"129","author":"Landgraf","year":"2007","journal-title":"Cell"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jhep.2014.10.004","article-title":"MiR-122\u2014A key factor and therapeutic target in liver disease","volume":"62","author":"Bandiera","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Benz, F., Roy, S., Trautwein, C., Roderburg, C., and Luedde, T. (2016). Circulating microRNAs as biomarkers for sepsis. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17010078"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1101\/gr.082701.108","article-title":"Most mammalian mRNAs are conserved targets of microRNAs","volume":"19","author":"Friedman","year":"2009","journal-title":"Genome Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1042\/BST20140142","article-title":"Regulation of miRNA strand selection: Follow the leader?","volume":"42","author":"Meijer","year":"2014","journal-title":"Biochem. Soc. Trans."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrm3838","article-title":"Regulation of microRNA biogenesis","volume":"15","author":"Ha","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nrc2867","article-title":"Genetic variation in microRNA networks: The implications for cancer research","volume":"10","author":"Ryan","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nrgastro.2013.87","article-title":"MicroRNAs in liver disease","volume":"10","author":"Szabo","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1073\/pnas.1222878110","article-title":"Genomic responses in mouse models poorly mimic human inflammatory diseases","volume":"110","author":"Seok","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/SHK.0000000000000153","article-title":"Abandon the mouse research ship? Not just yet!","volume":"41","author":"Osuchowski","year":"2014","journal-title":"Shock"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.1073\/pnas.0813371106","article-title":"Circulating microRNAs, potential biomarkers for drug-induced liver injury","volume":"106","author":"Wang","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/liv.12627","article-title":"Elevated miR-122 serum levels are an independent marker of liver injury in inflammatory diseases","volume":"35","author":"Roderburg","year":"2015","journal-title":"Liver Int."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1002\/hep.24538","article-title":"Circulating microRNAs as potential markers of human drug-induced liver injury","volume":"54","author":"Dear","year":"2011","journal-title":"Hepatology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/toxsci\/kfu232","article-title":"Application of high-throughput sequencing to circulating microRNAs reveals novel biomarkers for drug-induced liver injury","volume":"143","author":"Krauskopf","year":"2015","journal-title":"Toxicol. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Su, Y.W., Chen, X., Jiang, Z.Z., Wang, T., Wang, C., Zhang, Y., Wen, J., Xue, M., Zhu, D., and Zhang, Y. (2012). A panel of serum microRNAs as specific biomarkers for diagnosis of compound- and herb-induced liver injury in rats. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0037395"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1016\/j.ajpath.2015.08.020","article-title":"miR-223 deficiency protects against fas-induced hepatocyte apoptosis and liver injury through targeting insulin-like growth factor 1 receptor","volume":"185","author":"Qadir","year":"2015","journal-title":"Am. J. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1042\/CS20170218","article-title":"miR-223 represents a biomarker in acute and chronic liver injury","volume":"131","author":"Schueller","year":"2017","journal-title":"Clin. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Chen, W., Han, C., Zhang, J., Song, K., Wang, Y., and Wu, T. (2015). MiR-150 deficiency protects against fas-induced acute liver injury in mice through regulation of akt. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0132734"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1042\/CS20160216","article-title":"Down-regulation of miR-192-5p protects from oxidative stress-induced acute liver injury","volume":"130","author":"Roy","year":"2016","journal-title":"Clin. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"12224","DOI":"10.18632\/oncotarget.3652","article-title":"Identification of a novel TGF-\u03b2-miR-122-fibronectin 1\/serum response factor signaling cascade and its implication in hepatic fibrogenesis","volume":"6","author":"Zeng","year":"2015","journal-title":"Oncotarget"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.jhep.2017.06.007","article-title":"miR-1224 inhibits cell proliferation in acute liver failure by targeting the antiapoptotic gene nfib","volume":"67","author":"Roy","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.jhep.2016.01.035","article-title":"The pro-inflammatory effects of miR-155 promote liver fibrosis and alcohol-induced steatohepatitis","volume":"64","author":"Bala","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/hep.23922","article-title":"Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis","volume":"53","author":"Roderburg","year":"2011","journal-title":"Hepatology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1093\/infdis\/jir186","article-title":"Hepatitis c virus infection and hepatic stellate cell activation downregulate miR-29: miR-29 overexpression reduces hepatitis c viral abundance in culture","volume":"203","author":"Bandyopadhyay","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"7325","DOI":"10.18632\/oncotarget.2621","article-title":"MicroRNA-29b prevents liver fibrosis by attenuating hepatic stellate cell activation and inducing apoptosis through targeting PI3K\/AKT pathway","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1111\/j.1742-4658.2011.08075.x","article-title":"The rno-miR-34 family is upregulated and targets acsl1 in dimethylnitrosamine-induced hepatic fibrosis in rats","volume":"278","author":"Li","year":"2011","journal-title":"FEBS J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.12659\/MSM.894000","article-title":"MicroRNA-34a promotes hepatic stellate cell activation via targeting acsl1","volume":"21","author":"Yan","year":"2015","journal-title":"Med. Sci. Monit."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3892\/mmr.2014.2846","article-title":"MicroRNA-34a and microRNA-34c promote the activation of human hepatic stellate cells by targeting peroxisome proliferator-activated receptor gamma","volume":"11","author":"Li","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ajpath.2012.06.010","article-title":"Epigenetic regulation of miR-34a expression in alcoholic liver injury","volume":"181","author":"Meng","year":"2012","journal-title":"Am. J. Pathol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jhep.2012.10.015","article-title":"Hepatic and serum levels of miR-122 after chronic hcv-induced fibrosis","volume":"58","author":"Trebicka","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1172\/JCI63455","article-title":"MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis","volume":"122","author":"Tsai","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e302","DOI":"10.1111\/liv.12429","article-title":"Significance of serum and hepatic microRNA-122 levels in patients with non-alcoholic fatty liver disease","volume":"34","author":"Miyaaki","year":"2014","journal-title":"Liver Int."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00535-014-0932-4","article-title":"Antitumor function of microRNA-122 against hepatocellular carcinoma","volume":"49","author":"Nakao","year":"2014","journal-title":"J. Gastroenterol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2174\/1566523214666141224095610","article-title":"MiR-122 is a unique molecule with great potential in diagnosis, prognosis of liver disease, and therapy both as miRNA mimic and antimiR","volume":"15","author":"Thakral","year":"2015","journal-title":"Curr. Gene Ther."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1172\/JCI63539","article-title":"Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver","volume":"122","author":"Hsu","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/cbf.3252","article-title":"miR-199a-5p suppresses tumorigenesis by targeting clathrin heavy chain in hepatocellular carcinoma","volume":"35","author":"Huang","year":"2017","journal-title":"Cell Biochem. Funct."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"940","DOI":"10.7150\/jca.17496","article-title":"Mutual regulation of miR-199a-5p and HIF-1\u03b1 modulates the warburg effect in hepatocellular carcinoma","volume":"8","author":"Li","year":"2017","journal-title":"J. Cancer"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Zhou, M., Wang, S., Hu, L., Liu, F., Zhang, Q., and Zhang, D. (2016). MiR-199a-5p suppresses human bladder cancer cell metastasis by targeting CCR7. BMC Urol., 16.","DOI":"10.1186\/s12894-016-0181-3"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Song, J., Gao, L., Yang, G., Tang, S., Xie, H., Wang, Y., Wang, J., Zhang, Y., Jin, J., and Gou, Y. (2014). MiR-199a regulates cell proliferation and survival by targeting FZD7. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0110074"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cmet.2006.01.005","article-title":"MiR-122 regulation of lipid metabolism revealed by in vivo antisense targeting","volume":"3","author":"Esau","year":"2006","journal-title":"Cell Metab."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1172\/JCI44883","article-title":"The liver-specific microRNA miR-122 controls systemic iron homeostasis in mice","volume":"121","author":"Castoldi","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1101\/gad.1781009","article-title":"Integration of microRNA miR-122 in hepatic circadian gene expression","volume":"23","author":"Gatfield","year":"2009","journal-title":"Genes Dev."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1074\/jbc.M109.085431","article-title":"MicroRNAs regulate human hepatocyte nuclear factor 4\u03b1, modulating the expression of metabolic enzymes and cell cycle","volume":"285","author":"Takagi","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/hep.22656","article-title":"Hepatic function is preserved in the absence of mature microRNAs","volume":"49","author":"Hand","year":"2009","journal-title":"Hepatology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/liv.12496","article-title":"MicroRNAs: The fine modulators of liver development and function","volume":"34","author":"Chen","year":"2014","journal-title":"Liver Int."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1055\/s-0032-1301733","article-title":"Acute liver failure","volume":"33","author":"Lee","year":"2012","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1002\/hep.27250","article-title":"MicroRNAs play a role in spontaneous recovery from acute liver failure","volume":"60","author":"John","year":"2014","journal-title":"Hepatology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.3748\/wjg.v22.i4.1523","article-title":"Liver transplantation in acute liver failure: A challenging scenario","volume":"22","author":"Mendizabal","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Teschke, R., Schulze, J., Eickhoff, A., and Danan, G. (2017). Drug induced liver injury: Can biomarkers assist rucam in causality assessment?. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18040803"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1365-2613.2000.00144.x","article-title":"Animal models of acute hepatic failure","volume":"81","author":"Rahman","year":"2000","journal-title":"Int. J. Exp. Pathol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2131\/jts.32.401","article-title":"Changes of micro-RNA expression in rat liver treated by acetaminophen or carbon tetrachloride\u2014Regulating role of micro-RNA for RNA expression","volume":"32","author":"Fukushima","year":"2007","journal-title":"J. Toxicol. Sci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1002\/hep.25873","article-title":"Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases","volume":"56","author":"Bala","year":"2012","journal-title":"Hepatology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/hep.26294","article-title":"Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital","volume":"58","author":"Antoine","year":"2013","journal-title":"Hepatology"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Russo, M.W., Steuerwald, N., Norton, H.J., Anderson, W.E., Foureau, D., Chalasani, N., Fontana, R.J., Watkins, P.B., Serrano, J., and Bonkovsky, H.L. (2016). Profiles of miRNAs in serum in severe acute drug induced liver injury and their prognostic significance. Liver Int.","DOI":"10.1111\/liv.13312"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1503\/cmaj.1040752","article-title":"Liver enzyme alteration: A guide for clinicians","volume":"172","author":"Giannini","year":"2005","journal-title":"CMAJ"},{"key":"ref_60","first-page":"267","article-title":"Biomarkers in dili: One more step forward","volume":"7","author":"Stephens","year":"2016","journal-title":"Front. Pharmacol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1136\/gutjnl-2016-311861","article-title":"MicroRNA-223 ameliorates alcoholic liver injury by inhibiting the IL-6-p47phox-oxidative stress pathway in neutrophils","volume":"66","author":"Li","year":"2017","journal-title":"Gut"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1007\/s10620-008-0629-8","article-title":"Association of microRNA-223 expression with hepatic ischemia\/reperfusion injury in mice","volume":"54","author":"Yu","year":"2009","journal-title":"Dig. Dis. Sci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ajpath.2015.10.003","article-title":"Serum miR-30e and miR-223 as novel noninvasive biomarkers for hepatocellular carcinoma","volume":"186","author":"Bhattacharya","year":"2016","journal-title":"Am. J. Pathol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.bbadis.2014.03.005","article-title":"MiR-223: An inflammatory oncomir enters the cardiovascular field","volume":"1842","author":"Taibi","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/joim.12099","article-title":"MiR-223: Infection, inflammation and cancer","volume":"274","author":"Haneklaus","year":"2013","journal-title":"J. Intern. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1053\/gast.2002.30304","article-title":"Tumor necrosis factor \u03b1, but not fas, mediates hepatocellular apoptosis in the murine ischemic liver","volume":"122","author":"Rudiger","year":"2002","journal-title":"Gastroenterology"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"11916","DOI":"10.1038\/ncomms11916","article-title":"MicroRNA-125b-5p mimic inhibits acute liver failure","volume":"7","author":"Yang","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1128\/MCB.01408-13","article-title":"Notch-Nrf2 axis: Regulation of Nrf2 gene expression and cytoprotection by notch signaling","volume":"34","author":"Wakabayashi","year":"2014","journal-title":"Mol. Cell. Biol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.intimp.2016.09.011","article-title":"Fine-tuning the expression of microRNA-155 controls acetaminophen-induced liver inflammation","volume":"40","author":"Yuan","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/toxsci\/kfr130","article-title":"Involvement of microRNAs in dioxin-induced liver damage in the mouse","volume":"122","author":"Yoshioka","year":"2011","journal-title":"Toxicol. Sci."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Teschke, R., Larrey, D., Melchart, D., and Danan, G. (2016). Traditional chinese medicine (tcm) and herbal hepatotoxicity: Rucam and the role of novel diagnostic biomarkers such as microRNAs. Medicines, 3.","DOI":"10.3390\/medicines3030018"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3389\/fphar.2015.00236","article-title":"Integrated expression profiles of mRNA and microRNA in the liver of fructus meliae toosendan water extract injured mice","volume":"6","author":"Zheng","year":"2015","journal-title":"Front. Pharmacol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000090173","article-title":"Clinical syndromes of alcoholic liver disease","volume":"23","author":"Adachi","year":"2005","journal-title":"Dig. Dis."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/ncpgasthep0683","article-title":"Management strategies in alcoholic liver disease","volume":"4","author":"Tilg","year":"2007","journal-title":"Nat. Clin. Pract. Gastroenterol. Hepatol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/humrep\/den439","article-title":"Ethanol exposure induces differential microRNA and target gene expression and teratogenic effects which can be suppressed by folic acid supplementation","volume":"24","author":"Wang","year":"2009","journal-title":"Hum. Reprod."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1111\/j.1530-0277.2009.01007.x","article-title":"MicroRNA expression profile in lieber-decarli diet-induced alcoholic and methionine choline deficient diet-induced nonalcoholic steatohepatitis models in mice","volume":"33","author":"Dolganiuc","year":"2009","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1074\/jbc.M110.145870","article-title":"Up-regulation of microRNA-155 in macrophages contributes to increased tumor necrosis factor \u03b1 (TNF\u03b1) production via increased mRNA half-life in alcoholic liver disease","volume":"286","author":"Bala","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Lippai, D., Bala, S., Csak, T., Kurt-Jones, E.A., and Szabo, G. (2013). Chronic alcohol-induced microRNA-155 contributes to neuroinflammation in a TLR4-dependent manner in mice. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0070945"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1093\/carcin\/bgp277","article-title":"MicroRNA expression in head and neck cancer associates with alcohol consumption and survival","volume":"30","author":"Avissar","year":"2009","journal-title":"Carcinogenesis"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"E59","DOI":"10.1111\/j.1530-0277.2012.01852.x","article-title":"Chronic ethanol feeding alters miRNA expression dynamics during liver regeneration","volume":"37","author":"Dippold","year":"2013","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.cld.2008.07.008","article-title":"Cellular sources of extracellular matrix in hepatic fibrosis","volume":"12","author":"Wells","year":"2008","journal-title":"Clin. Liver Dis."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jhep.2008.11.025","article-title":"MiR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: An essential role for apoptosis","volume":"50","author":"Guo","year":"2009","journal-title":"J. Hepatol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/hep.25613","article-title":"Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis","volume":"56","author":"Lakner","year":"2012","journal-title":"Hepatology"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.3748\/wjg.v17.i22.2748","article-title":"MiRNA studies in in vitro and in vivo activated hepatic stellate cells","volume":"17","author":"Maubach","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1111\/j.1742-4658.2009.07213.x","article-title":"Changes in microRNAs associated with hepatic stellate cell activation status identify signaling pathways","volume":"276","author":"Guo","year":"2009","journal-title":"FEBS J."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"13027","DOI":"10.1073\/pnas.0805038105","article-title":"Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis","volume":"105","author":"Sutherland","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Kwiecinski, M., Noetel, A., Elfimova, N., Trebicka, J., Schievenbusch, S., Strack, I., Molnar, L., von Brandenstein, M., Tox, U., and Nischt, R. (2011). Hepatocyte growth factor (HGF) inhibits collagen i and iv synthesis in hepatic stellate cells by miRNA-29 induction. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0024568"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fphys.2012.00049","article-title":"MicroRNA are central players in anti- and profibrotic gene regulation during liver fibrosis","volume":"3","author":"Noetel","year":"2012","journal-title":"Front. Physiol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/labinvest.2012.70","article-title":"Expression of platelet-derived growth factor-c and insulin-like growth factor i in hepatic stellate cells is inhibited by miR-29","volume":"92","author":"Kwiecinski","year":"2012","journal-title":"Lab. Investig. J. Tech. Methods Pathol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"14851","DOI":"10.1074\/jbc.M111.314922","article-title":"Protective role of estrogen-induced miRNA-29 expression in carbon tetrachloride-induced mouse liver injury","volume":"287","author":"Zhang","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"872","DOI":"10.18632\/oncotarget.1825","article-title":"MiR-34: From bench to bedside","volume":"5","author":"Agostini","year":"2014","journal-title":"Oncotarget"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.bcp.2014.05.002","article-title":"Retinoid x receptor \u03b1 in human liver is regulated by miR-34a","volume":"90","author":"Oda","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"18066","DOI":"10.1074\/jbc.M110.196451","article-title":"Two-tiered approach identifies a network of cancer and liver disease-related genes regulated by miR-122","volume":"286","author":"Boutz","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jhep.2016.05.048","article-title":"MiR-122 expression is not regulated during activation of hepatic stellate cells","volume":"65","author":"Schueller","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jhep.2012.11.011","article-title":"MiR-122 regulates collagen production via targeting hepatic stellate cells and suppressing P4HA1 expression","volume":"58","author":"Li","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.3892\/or.2015.4275","article-title":"MicroRNAs involved with hepatocellular carcinoma (review)","volume":"34","author":"Mao","year":"2015","journal-title":"Oncol. Rep."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000323886","article-title":"Ash and nash","volume":"29","author":"Scaglioni","year":"2011","journal-title":"Dig. Dis."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Mehra, M., and Chauhan, R. (2017). Long noncoding RNAs as a key player in hepatocellular carcinoma. Biomark. Cancer, 9.","DOI":"10.1177\/1179299X17737301"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"6092","DOI":"10.1158\/0008-5472.CAN-06-4607","article-title":"Cyclin g1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma","volume":"67","author":"Gramantieri","year":"2007","journal-title":"Cancer Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"32015","DOI":"10.1074\/jbc.M109.016774","article-title":"MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib","volume":"284","author":"Bai","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1002\/hep.23875","article-title":"A novel GSK-3 \u03b2-C\/EBP \u03b1-miR-122-insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma","volume":"52","author":"Zeng","year":"2010","journal-title":"Hepatology"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ccr.2011.01.001","article-title":"Identification of mirnomes in human liver and hepatocellular carcinoma reveals miR-199a\/b-3p as therapeutic target for hepatocellular carcinoma","volume":"19","author":"Hou","year":"2011","journal-title":"Cancer Cell"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"5184","DOI":"10.1158\/0008-5472.CAN-10-0145","article-title":"miR-199a-3p regulates mtor and c-met to influence the doxorubicin sensitivity of human hepatocarcinoma cells","volume":"70","author":"Fornari","year":"2010","journal-title":"Cancer Res."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Varshney, A., Panda, J.J., Singh, A.K., Yadav, N., Bihari, C., Biswas, S., Sarin, S.K., and Chauhan, V.S. (2017). Targeted delivery of miR-199a-3p using self-assembled dipeptide nanoparticles efficiently reduces hepatocellular carcinoma. Hepatology.","DOI":"10.1002\/hep.29643"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.bbrc.2010.10.130","article-title":"miR-199a-3p targets CD44 and reduces proliferation of CD44 positive hepatocellular carcinoma cell lines","volume":"403","author":"Henry","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"e2706","DOI":"10.1038\/cddis.2017.123","article-title":"MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF and MMP2","volume":"8","author":"Ghosh","year":"2017","journal-title":"Cell Death Dis."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/1\/261\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T14:51:28Z","timestamp":1760194288000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/1\/261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,16]]},"references-count":106,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1]]}},"alternative-id":["ijms19010261"],"URL":"https:\/\/doi.org\/10.3390\/ijms19010261","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,16]]}}}